Immune Tolerance Network

ABOUT US The Immune Tolerance Network (ITN) is a collaborative network for clinical research, funded by the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health. Our mission is to accelerate the clinical development of immune tolerance therapies. Immune tolerance therapies reprogram the immune system so that disease-causing immune responses are stopped while maintaining the immune system’s ability to combat pathogen infection. The ITN develops and conducts clinical trials, each supported by mechanistic studies, of specialized immune tolerance therapies in the following areas: Autoimmune Disease llergies and Asthma Organ Transplantation Type 1 Diabetes MISSION VALUES The Immune Tolerance Network (ITN) is an organization born from the collective vision of the National Institute of Allergy and Infectious Disease (of the National Institutes of Health) and the tolerance research community. As such, our vision and the principles upon which we were founded are a reflection of the community itself. Our Statement of Values and Commitments clearly defines these principles and provides a framework that guides us in our activities. This commitment ensures that we will continue as strong advocates for the community in an open and accessible manner. OUR MISSION To advance the clinical application of immune tolerance by performing high quality clinical trials of emerging therapeutics integrated with mechanism-based research. In particular, we aim to: Establish new tolerance therapeutics Develop a better understanding of the mechanisms of immune function and disease pathogenesis Identify new biomarkers of tolerance and disease Our Purpose To understand and achieve immune tolerance to prevent and cure human disease. OUR VALUES Innovation: We anticipate and respond to each challenge, research or otherwise, with creativity and passion, welcoming the challenge of attempting what has never been accomplished before. Integrity: We strive for fairness, truth and respect in all that we do and uphold high ethical standards in all human research. Conviction: We are firm in our belief that immune tolerance therapies can and will radically improve human health. Collaboration: We are built upon teamwork, establishing partnerships with academia, government and industry to meet our goals. We are committed to the scientific ideals of openness and the sharing of scientific information. OUR COMMITMENTS We make the following commitments in order to fulfill our purpose and translate our values into our every day work. - We will lead by example and use our collective resources and expertise to rapidly advance the field of tolerance research. - We will share the results of our scientific endeavors with the research community in a timely, open manner. - We will uphold the highest ethical standards in all that we do. - We will ensure that the Immune Tolerance Network provides an outstanding work environment. - We will be accountable for living up to our commitments.